BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 17, 2008
View Archived Issues
Panacos presents update on HIV drug pipeline
Read More
AstraZeneca returns worldwide rights to Hsp90 drugs IPI-504 and IPI-493 to Infinity
Read More
Capstone presents positive safety results for AZX-100 in dermal scarring
Read More
Chroma presents positive phase II efficacy data for tosedostat in AML
Read More
First phase III results released for FTY-720, a novel oral therapy for MS
Read More
Impax discusses phase III IPX-056 trial results with FDA
Read More
BAY-73-4506 investigated for preclinical effects in multiple myeloma
Read More
Stelara approved in Canada for moderate to severe plaque psoriasis
Read More
Baxter treats first patient in phase I recombinant von Willebrand factor trial
Read More
Cylene commences phase II quarfloxin trial in carcinoid/neuroendocrine tumors
Read More
Lundbeck initiates phase III clinical trials with nalmefene for alcohol dependence
Read More
Synvista treats first patient in SYI-2074 trial for psoriasis
Read More
Vivus initiates phase III avanafil trial in erectile dysfunction
Read More
Genfit commences phase II GFT-505 trial in patients with prediabetes
Read More
Shionogi launches Pirespa in Japan
Read More
FDA approves Abbott's Trilipix for patients with mixed dyslipidemia
Read More
FDA approves Mozobil to mobilize hematopoietic stem cells in transplantation
Read More
Synosia initiates proof-of-concept trial of nitisinone in RLS
Read More
LCT reports results from preclinical rat studies of NeurotrophinCell in PD
Read More
High rate of response seen with pomalidomide and dexamethasone in relapsed multiple myeloma
Read More
AN-3520 as a potential treatment for human African trypanosomiasis
Read More
EXTEND, RAISE studies add to data on recently approved eltrombopag
Read More
Novel Syk inhibitor prevents heparin-induced thrombocytopenia in vivo
Read More
Recent patents describe novel agents for neuropsychiatric disorders
Read More
Recent Novartis patent discloses new therapeutic agents for transplant rejection
Read More
New contraceptive agents reported in recent Organon patent
Read More